| URL | https://www.contractpharma.com/contents/view_break |
| Source | Contract Pharma |
| Date Published | 12/05/2022 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Purolite |
| Parent company | Ecolab |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 75 |
| Year reshoring announced: | 2022 |
| City reshored to: | King of Prussia |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | ion exchange resins |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Infrastructure, Lead time/Time to market, Proximity to customers/market |